Drupal.behaviors.print = function(context) {window.print();window.close();}>

Affomix to Select mAbs for Kalgene Pharma

December 29, 2009

Affomix to Select mAbs for Kalgene Pharma

By a GenomeWeb staff reporter

Affomix will use its Y2HExpress technology to select antibodies for Kalgene with potential diagnostic and therapeutic use in breast cancer.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories